Dengue shock syndrome

Dengue shock syndrome
United States Military · Public domain · source
Name	Dengue shock syndrome
Synonyms	Severe dengue with shock
Specialty	Infectious disease, Critical care medicine, Emergency medicine
Symptoms	Hypotension, cold clammy skin, narrow pulse pressure, bleeding manifestations
Complications	Multi-organ failure, Hemorrhagic fever, Shock (circulatory)

Dengue shock syndrome is a severe, life‑threatening complication of dengue virus infection characterized by plasma leakage leading to hypovolemic shock. It most commonly follows secondary infection with a different serotype of Dengue virus and requires rapid recognition and supportive care in settings such as Intensive care units or Emergency departments. Risk factors include prior dengue exposure, young age, and comorbidities managed by specialists in Pediatrics and Internal medicine.

Signs and symptoms

Patients present with abrupt deterioration after the febrile phase, showing hypotension, narrow pulse pressure and signs of poor perfusion such as cold extremities comparable to presentations seen in Septic shock and Cardiogenic shock. Bleeding manifestations may include mucosal hemorrhage, petechiae and gastrointestinal bleeding reminiscent of cases reported in Hemorrhagic fever outbreaks; organ-specific findings can involve oliguria similar to presentations in Acute kidney injury and altered consciousness paralleling severe Encephalopathy described in other viral syndromes. Laboratory features frequently show hemoconcentration with rising hematocrit, thrombocytopenia and coagulopathy that clinicians trained in Hematology often correlate with disseminated intravascular coagulation seen in Ebola virus disease and severe Malaria.

Pathophysiology

Pathogenesis centers on increased vascular permeability produced by interactions between immune responses to different dengue serotypes and viral factors, a mechanism discussed in immunology literature alongside antibody-dependent enhancement described for Zika virus and Yellow fever virus. Endothelial dysfunction leads to plasma extravasation into serous cavities, producing pleural effusions and ascites similar to descriptions in Capillary leak syndrome. Proinflammatory cytokines and complement activation, pathways also implicated in Cytokine release syndrome and severe Coronavirus disease 2019 cases, drive hemodynamic instability; cardiac impairment analogous to viral myocarditis in Coxsackievirus infections may exacerbate shock. Genetic susceptibility loci explored in population studies involving World Health Organization partner institutions and national research centers contribute to variable clinical severity across outbreaks in locations such as Brazil, Philippines, Thailand and India.

Diagnosis

Diagnosis relies on clinical recognition supported by laboratory and imaging studies used in settings operated by entities like Centers for Disease Control and Prevention and national public health agencies. Serological tests (IgM/IgG) and molecular detection by RT‑PCR for dengue viral RNA are performed in reference laboratories similar to workflows for Influenza A virus and SARS-CoV-2 testing; interpretation must account for cross‑reactivity with flaviviruses such as Zika virus and Yellow fever virus. Hematologic monitoring documents rising hematocrit and falling platelet counts, while chest radiography or ultrasound—tools used in Radiology and Point-of-care ultrasound programs—identifies pleural effusions and guided fluid management. Differential diagnoses include septic shock from bacterial pathogens addressed by Infectious Diseases Society of America guidelines, severe malaria diagnosed with microscopy as practiced in World Health Organization endemic area programs, and other tropical febrile illnesses evaluated by global networks like Médecins Sans Frontières.

Management and treatment

Management prioritizes timely fluid resuscitation and hemodynamic support modeled on protocols from Surviving Sepsis Campaign and adapted by national ministries of health during dengue epidemics. Isotonic crystalloid boluses and careful titration to restore perfusion are standard, with invasive monitoring and vasoactive agents administered under guidance from Critical care medicine teams when shock persists; packed red blood cells or platelet transfusions follow transfusion thresholds established by societies such as the American Association of Blood Banks. Adjunctive measures include oxygen therapy and airway support often provided in Anesthesiology and critical care settings, while analgesia and antipyretics are chosen to avoid nonsteroidal anti-inflammatory drugs implicated in bleeding risk, a principle echoed in guidelines for hemorrhagic fevers from World Health Organization. Experimental and preventive strategies including vaccine programs developed by consortia involving Sanofi, national vaccine institutes and academic centers have influenced public health response but do not replace acute supportive care.

Prognosis and complications

With prompt recognition and aggressive supportive care outcomes can be favorable, whereas delayed treatment increases risks of persistent shock, multi‑organ failure and death, patterns documented in hospital series from Singapore, Vietnam and Colombia. Complications include severe hemorrhage, acute respiratory distress syndrome with parallels to cases in H1N1 influenza and COVID-19 pandemics, renal failure requiring renal replacement therapy as seen in critical care cohorts, and long-term morbidities reported in cohort studies led by university hospitals such as Johns Hopkins University and University of São Paulo. Mortality has declined where intensive care capacity and early warning systems coordinated by public health agencies are available.

Epidemiology and prevention

Dengue shock syndrome occurs within the global burden of dengue, which has expanded with urbanization and travel linking cities like Miami, Barcelona, Kuala Lumpur and Manila. Large outbreaks reported in regions including Southeast Asia, Latin America and parts of Africa prompted surveillance by World Health Organization and national centers like Centers for Disease Control and Prevention for containment. Prevention focuses on vector control targeting Aedes aegypti breeding sites using methods employed by municipal public works departments and vector control programs in partnership with organizations such as Pan American Health Organization; personal protective measures promoted by ministries of health and community groups reduce exposure. Vaccination strategies developed by multinational collaborations and regulatory approvals by agencies such as the European Medicines Agency and national regulatory authorities form part of integrated prevention, while travel advisories issued by foreign ministries and public health institutions inform individual risk mitigation.

Category:Viral diseases